Azione A096530 SEEGENE, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Seegene, Inc.

Azioni

A096530

KR7096530001

Prezzo di chiusura Korea S.E.
Altri mercati azionari
 00:00:00 30/04/2024 		Variaz. 5gg Var. 1 gen.
22.150 KRW -0,67% Grafico intraday di Seegene, Inc. +1,14% -3,28%
14/03 Seegene, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI
24/01 Seegene Inc. annuncia la collaborazione con Microsoft per realizzare un mondo libero da tutte le malattie CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases
Seegene obtains ISO45001 certification
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing
Microbix Brief: Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on July 13, 2023.
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.
Seegene, Inc.'s Equity Buyback announced on February 28, 2023, has expired with 2,046,354 shares, representing 4.11% for KRW 49,998.4 million.
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
Seegene, Inc. authorizes a Buyback Plan.
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione A096530
  4. Notizie Seegene, Inc.
  5. Altre lingue